Cargando…
A Double‐blind, Placebo‐controlled, Multicenter, Prospective, Randomized Study of Beraprost Sodium Treatment for Cats with Chronic Kidney Disease
BACKGROUND: Chronic kidney disease (CKD) is a common progressive and irreversible disease in cats. The efficacy and safety of beraprost sodium (BPS) in cats with CKD have not been evaluated. HYPOTHESIS/OBJECTIVES: To evaluate the efficacy and safety of BPS in the treatment of cats with CKD, as compa...
Autores principales: | Takenaka, M., Iio, A., Sato, R., Sakamoto, T., Kurumatani, H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787173/ https://www.ncbi.nlm.nih.gov/pubmed/29131397 http://dx.doi.org/10.1111/jvim.14839 |
Ejemplares similares
-
Multicenter, randomized, double‐blinded, placebo‐controlled study of rabacfosadine in dogs with lymphoma
por: Weishaar, Kristen M., et al.
Publicado: (2021) -
Appetite‐stimulating effects of once‐daily omeprazole in cats with chronic kidney disease: Double‐blind, placebo‐controlled, randomized, crossover trial
por: Spencer, Ashley, et al.
Publicado: (2021) -
Evaluation of benazepril in cats with heart disease in a prospective, randomized, blinded, placebo‐controlled clinical trial
por: King, Jonathan N., et al.
Publicado: (2019) -
Safety and efficacy of orally administered telmisartan for the treatment of systemic hypertension in cats: Results of a double‐blind, placebo‐controlled, randomized clinical trial
por: Coleman, Amanda E., et al.
Publicado: (2019) -
Effects of Benazepril on Survival of Dogs with Chronic Kidney Disease: A Multicenter, Randomized, Blinded, Placebo‐Controlled Clinical Trial
por: King, J.N., et al.
Publicado: (2017)